Aligos Therapeutics Inc., of South San Francisco, appointed Lesley Ann Calhoun chief financial officer.
Confo Therapeutics NV, of Ghent, Belgium, appointed Paolo Vicini chief development officer, effective June 1, 2020.
Hemostemix Inc., of Calgary, Alberta, appointed Mary Argent-Katwala manager, clinical trials.
Ocugen Inc., of Malvern, Pa., appointed Mohamed Genead chair of its retina scientific advisory board.
Oxford Biodynamics plc, of Oxford, U.K., appointed Peter Pack independent non-executive chair of its board.
Sirtex Medical US Holdings Inc., of Woburn, Mass., appointed Mark A. Turco global chief medical officer and executive vice president of research and development, effective June 1, 2020.
Vaxcyte Inc., of Foster City, Calif., appointed Halley E. Gilbert to its board.